chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had immediate soreness at the injection site. Later that evening around 9:30 I felt very weak and shakey. I had a bad headache, fever, chills, muscle aches, and nausea. I couldn't hold down water of food. At 10am the following day (3/21) I was able to take aTylenol and the fever came down. So far, I have taken Tylenol throughout the day and kept the fever down, however I still get bad night sweats and muscle aches. Today (3/23) I feel a little off, but much better.
The night after receiving vaccinations, he was noted to have circumoral pallor and listlessness. Taken to ER but didn't go in because he recovered.
Staff member presented to Hospital to inform of probable reaction to COVID-19 Vaccine.  Has generalizes red, raised, itchy rash to her body...Employee health nurse observed rash area to exposed skin areas of neck and arms.  Denies any SOB/dyspnea/throat or tongue swelling. States rash has been present for about 5 days. States has history of delayed rash response to various meds and vaccines where she needs to take Benadryl and sometimes steroids. Has been completed CDC daily questionnaire since about day 4 post vaccination.
swelling in the injection site; pain in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (swelling in the injection site) and VACCINATION SITE PAIN (pain in the injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Bee sting hypersensitivity and Ant bite.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE SWELLING (swelling in the injection site) and VACCINATION SITE PAIN (pain in the injection site). At the time of the report, INJECTION SITE SWELLING (swelling in the injection site) and VACCINATION SITE PAIN (pain in the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. No Treatments were reported.   Reporter did not allow further contact
+ confluent immaculate rash w/fever, runny nose, coughing but child playing normally;pt was put on Amoxicillin/Ibuprofen & APAP;
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 12Apr2021 as dose 1, single (Lot number: EW061), on 10May2021 as dose 2, single (Lot number: EW0168) and on 20Dec2021 as dose 3 (booster), single (Lot number: 331308A) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 17Jan2023, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jan2023) Negative, notes: Tested negative for 4 days; (Jan2023) Negative, notes: Tested negative for 4 days; (Jan2023) Negative, notes: Tested negative for 4 days; (Jan2023) Negative, notes: Tested negative for 4 days; (17Jan2023) Positive, notes: Tested positive and started Paxlovid; (21Jan2023) Positive, notes: By day 5 I was very much improved but still tested positive; (24Jan2023) Negative; (25Jan2023) Positive, notes: Positive COVID test (no noticeable symptoms); (26Jan2023) Positive, notes: Positive COVID test (noticing return of congestion); (28Jan2023) Positive, notes: Positive COVID test (more noticeable but mild symptoms with congestion, soar throat, fatigue); (29Jan2023) Positive, notes: Positive COVID test (same symptoms as the day before)-Day 13. Therapeutic measures were taken as a result of vaccination failure, covid-19.
Can't walk; Veins varicose in legs; Too much pressure in my legs; Swelling of the legs; Redness from site of injection to the elbow; Redness from site of injection to the elbow; Swelling of the arm; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Redness from site of injection to the elbow), GAIT DISTURBANCE (Can't walk), VARICOSE VEIN (Veins varicose in legs), LIMB DISCOMFORT (Too much pressure in my legs) and PERIPHERAL SWELLING (Swelling of the arm) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     No medical history provided.  Concomitant products included LEVOTHYROXINE and FLUCONAZOLE (FLUCONAZOL) for an unknown indication.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced PYREXIA (Fever). On 06-May-2021, the patient experienced HEADACHE (Headache). On 08-May-2021, the patient experienced INJECTION SITE ERYTHEMA (Redness from site of injection to the elbow), PERIPHERAL SWELLING (Swelling of the arm) and ERYTHEMA (Redness from site of injection to the elbow). On 14-May-2021, the patient experienced GAIT DISTURBANCE (Can't walk), VARICOSE VEIN (Veins varicose in legs), LIMB DISCOMFORT (Too much pressure in my legs) and PERIPHERAL SWELLING (Swelling of the legs). The patient was treated with IBUPROFEN on 06-May-2021 for Fever, at an unspecified dose and frequency. On 06-May-2021, PYREXIA (Fever) and HEADACHE (Headache) had resolved. At the time of the report, INJECTION SITE ERYTHEMA (Redness from site of injection to the elbow), GAIT DISTURBANCE (Can't walk), VARICOSE VEIN (Veins varicose in legs), LIMB DISCOMFORT (Too much pressure in my legs), PERIPHERAL SWELLING (Swelling of the arm), PERIPHERAL SWELLING (Swelling of the legs) and ERYTHEMA (Redness from site of injection to the elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient gave consent to follow-up by safety.   Reporter did not allow further contact
Pt woke up the day after vaccination with hives all over body but especially a large red area to the left leg, where she had received the vaccination.
Narrative: 72 y/o male who received first dose of COVID-19 vaccination (Pfizer) and never returned for second dose. Shortly after first dose was administered, patient was admitted to the hospital for sepsis.
Patient have not received second dose 47 days after first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient have not received second dose 47 days after first dose) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient have not received second dose 47 days after first dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient have not received second dose 47 days after first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Itchiness worsened; This case was reported by a pharmacist via call center representative and described the occurrence of pruritus aggravated in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pruritus (received 1st dose in September 2019, refer case US2020135591).   In December 2019, the patient received the 2nd dose of Shingrix. On an unknown date, less than 9 months after receiving Shingrix, the patient experienced pruritus aggravated. The patient was treated with benadryl (nos) (Benadryl), antihistamine (Antihistaminic), corticosteroid nos (Corticosteroid (Trade Name Unknown)) and steroids nos (Steroids). On an unknown date, the outcome of the pruritus aggravated was recovering/resolving.   It was unknown if the reporter considered the pruritus aggravated to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient received Shingrix and after that dose the itchiness worsened.  The patient consulted a physician who examined the patient and run tests liver, kidney as reported and no alternative explanations for the itchiness were found by the patient´s physician.  The pharmacist also reported that Benadryl and other antihistaminic drugs did not work for the itchiness which only improved after the administration of corticosteroids.  The patient was currently receiving steroids The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020135591:same reporter
optic neuritis, scleritis, idiopathic orbital inflammation - VISION LOSS LEFT EYE, and ongoing inflammation now requiring immunosuppression
She had another booster shot last Sep 2022 and when she woke up it was all over her body; She had another booster shot last Sep 2022 and when she woke up it was all over her body; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), on 20Sep2022 as dose 4,(booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 Immunization; Bnt162b2 (DOSE 3 (BOOSTER), SINGLE), administration date: Apr2021, for COVID-19 Immunization, reaction(s): "Caller mentioned she had a booster shot last April of the Pfizer Covid-19 vaccine. She woke up when had some rash on her legs and the doctor told her it's psoriasis.", "Caller mentioned she had a booster shot last April of the Pfizer Covid-19 vaccine. She woke up when had some rash on her legs and the doctor told her it's psoriasis.". The following information was reported: PSORIASIS (non-serious), RASH (non-serious) all with onset Sep2022, outcome "unknown" and all described as "She had another booster shot last Sep 2022 and when she woke up it was all over her body".  Additional Information: The patient received another last Sep 2022 and when she woke up it was all over her body. She would like to know if there is any medication for that.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202200078216 same reporter/patient/adverse events and different dose number;
Pfizer 4/13/21 and 5/4/21. Positive on 1/20/22
I recieved my vaccine and within 2 days I started to develop chest / heart pain in my right side.  It wasn't triggered by anything at all.  this continued for about two months then I got COVID - waste of time tog get the vaccine.  The chest/heart pain remained intermittent coming at times for a few seconds and others for a few minutes.  Nothing specifically triggered it like exertion.  this has continued for over a year now and regret not typing this out earlier.  This was the Pfizer covid booster that I had when the CDC decicded to continue the bogus fear but of Omicron.  Lies lies lies continue.  I have been worked up by a cardiologist and things are negative but the heart / chest pain remains intermittent.
Patient was hospitalized, presenting to the ED with confusion/encephalopathy.  She was also found during her hospitalization to have hypoglycemia, CAP, UTI, and liver cirrhosis with elevated LFTs/ammonia. She was given antibiotics and lactulose to manage. Patient recovered and was later discharged
Swelling left thigh 3/4cm no Rx needed. No erythema, no tenderness, resolved without rx.
Pericarditis. Treated with Advil and colchicine for three months following. Had follow up echocardiogram.
This case was reported by a healthcare professional and described the occurrence of not responding to therapy in an adult female subject who was vaccinated with HEPATITIS B vaccine, (manufacturer unspecified).  The reporter was the subject.  On an unspecified date the subject received the first series of HEPATITIS B vaccine (unknown).  At an unspecified time after vaccination with the first series of HEPATITIS B vaccine, the subject experienced not responding to therapy.  The subject reported that she did respond after the second series.  At the time of reporting the outcome of the event was unspecified.
After the last vaccine which was HPV, patient had syncopal episode and jerking movement for few seconds. ammonia given and patient's conscious returned. placed patient on recliner chair with Trendelenburg position. initial BP was 74/58, HR:101. patient and mother stated that she did not eat before vaccination. water and gonorla bar were provided. BP rechecked 108/76. HR:88. Patient stated that she felt much better. Denies pain or discomfort. Advised patient to rest yesterday. if any abnormal signs are found again, patient and parents were told to call the clinic or pmd or go to nearest ER. They verbalized understanding.
This spontaneous report as received from a nurse practitioner refers to a 41 year old female patient with asthma. On 03-JUN-2013 at 2 pm, the patient was vaccinated with PNEUMOVAX 23 intramuscularly into unspecified arm. Concomitant therapies included fluticasone propionate, ADVAIR, ALBUTEROL, CLARITIN and PRILOSEC. The patient reported that on 03-JUN-2013 at 5 pm to 6 pm, the patient experienced significant pain, redness and itching at the injection site. Her vaccinated arm also swelled significantly from her elbow up to and including shoulder. The patient called the office on 04-JUN-2013 to report this and an unspecified nurse instructed her to use ice packs to reduce the swelling. The patient subsequently visited the nurse practitioner at the office on 05-JUN-2013, where she took measurements of the patient's upper arm to determine the significance of the swelling. The unvaccinated arm measured 28.75 cm in diameter and the vaccinated arm measured 30 cm in diameter. The patient stated that her arm fells better than "yesterday" (04-JUN-2013), but she reported on 05-JUN-2013 that she had a mild headache, both frontal and bi-temporal. The nurse practitioner instructed the patient on 05-JUN-2013 to take BENADRYL for the swelling. The outcome of headache, both frontal and bi-temporal is unknown. Additional information has been requested.
Fever, chills, severe joint pain, severe fatigue causing me to sleep 32 hours in a 36 hour period
Pt recvd HIB vax 6MAR92 & w/in 24 hrs pt devel fever to 104 but was exhibiting nl behavior; 11MAR92 pt devel vomiting & loose bowel movements;
A spontaneous report was received on 25-NOV-2014 from a female physician, who was also the patient. On an unspecified date, the female received an injection of ZOSTAVAX (route and lot number not provided). Medical history and concomitant medications were not provided. In November 2014 (reported as "about a week ago") after receiving the injection, she developed redness, itchiness and "wheel" at the injection site. At the time of the report, the redness had migrated to the elbow. The physician/patient declined to provide any further information at the time of the report. The redness at the injection site was not recovered. The outcomes of the itchiness and "wheel" at injection site were unknown. Additional information has been requested.
My son had 4 vaccines: HEP B, HEP C, meningitis, flu. He has had a fever of 101.5 at it?s highest which responds to ibuprofen, pain at the injection site, and a severe headache. We are on day three now of symptoms.
Patient repoted swelling around the injection site and arm pain which started 2-3 days after the vaccine.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 13Aug2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 63 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Multiple sclerosis" (unspecified if ongoing). Concomitant medication(s) included: GLATIRAMER ACETATE, start date: Mar2012. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: COVID 19 Treatment; (15Nov2022) Positive, notes: positive covid test. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional information: Patient received other medication in weeks. Patient had no known allergies. Adverse event: coughing, headache, diarrhea, congestion, mild chest pain, positive covid test.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Information has been received from a LPN concerning her 14 year old daughter who was vaccinated with Gardasil. There was no concomitant medication. Subsequently, the patient experienced nausea. The patient sought unspecified medical attention. Addition information has been requested.
Second dose of Pfizer Covid vaccine and felt nothing until the same night.  woke up around midnight with extreme chills, shivering and chattering teeth, extreme headache, then developed 102 degree fever and extreme headache.  Was bedridden the entire following day, without appetite or ability to move.  Frankly, this is among the sickest I have ever been in my entire life and it?s troubling to know that it was caused by a vaccine.  Two days later, symptoms have subsided other than a headache.
It started out with asthma, it felt like I was breathing in glass. Someone in my office felt the same. I switched to my Trilogy inhaler, It was under control. A few days later I was having more and more symptoms of sinus congestion. Because of medication I am on, I keep taking what I had, and it did not last very long maybe a week. My asthma symptoms lasted a couple of days. I did contract COVID-19 on 12/22/2023. I started out with a laryngitis symptom and had a rust voice. I used a at home COVID-19 test and it said, I was positive. By that afternoon I had a fever the first in 40 years, it was like 99.8 it almost got up to 102 by the next day. I did a telehealth with my General Practitioner and was prescribed a cough syrup and Paxlovid type of medication that started with a "M". It was for 5 days, It really was only three days of symptoms. My fever broke on the third day, and I got a terrible sinus infection after COVID-19. It took me months to get rid of, I got a 10-day antibiotic course and finally it's cleared now.
SITE OF INJECTION WITH ERYTHEMIC FIRM AREA OF 6X6 CM WITH INJECTION SITE IN MIDDLE --
About 6 hours later I fell.  My legs could not hold me up. Next day I felt very weak, If I had to walk I had to hold on furniture, a general body weakness.  At this time,  pretty well recovered. The doctor sent in for full blood workup and chest scan and a brain scan and also the virus test.
Lot number AS1903B was involved in a temperature excursion that to place at HCP office on 13-Feb-2023; No adverse event; Patient administered the vaccine which underwent temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Lot number AS1903B was involved in a temperature excursion that to place at HCP office on 13-Feb-2023), POOR QUALITY PRODUCT ADMINISTERED (Patient administered the vaccine which underwent temperature excursion) and NO ADVERSE EVENT (No adverse event) in a 3-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1903B) for COVID-19 prophylaxis.     It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On 15-Feb-2023, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2023, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient administered the vaccine which underwent temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Lot number AS1903B was involved in a temperature excursion that to place at HCP office on 13-Feb-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Lot number AS1903B was involved in a temperature excursion that to place at HCP office on 13-Feb-2023), POOR QUALITY PRODUCT ADMINISTERED (Patient administered the vaccine which underwent temperature excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Lot number AS1903B was involved in a temperature excursion that to place at HCP office on 13-Feb-2023) and POOR QUALITY PRODUCT ADMINISTERED (Patient administered the vaccine which underwent temperature excursion).    No concomitant information was reported. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-715951 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-715951:Master Case - Child
After taking Moderna COVID-19 Vaccine EUA: About 10 minutes after injection, I noticed a slight lightheadedness, slightly increased heart rate yet I was already anxious, and a very faint tingling in lower lip and end of tongue. Between 1-2 hours after injection, I noticed a little bit of a scratchy throat,  increased thirst, and mild headache. No treatment required.  I took Benadryl and Tylenol when I returned home from my shift at work about 4 hours after the injection. The next day, 1/3/21, scratchy throat had disappeared.  I felt tired, slight fever of 99.5, increased thirst, and very sore arm.   On 1/4/21, I just have slightly sore arm and a little tired with no fever.  I took Tylenol.
Swelling of entire upper arm down to the elbow and redness. Patient was going to take Benadryl and ibuprofen.